Patent details

92915 Product Name: "Ivermectine pour son usage dans le traitement de la rosacée"

Basic Information

Publication number:
92915
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP047288113
Legal Status:
Lapsed
Application number:
92915
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
LU2015070124 - SOOLANTRA
Marketing Authorization Type:
Marketing Authorization Date:
18/06/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

2

Marketing Authorization Number:
MA117/01101 - SOOLANTRA
Marketing Authorization Type:
Marketing Authorization Date:
02/04/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Malta (MT)

Dates

Filing date:
17/12/2015
First Marketing Authorization date:
02/04/2015
Grant date:
17/02/2016
Activation date:
Publication date:
17/02/2016
Lapsed date:
22/04/2024
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
22/04/2029
SPC Extension Expiration:
22/04/2029
Rejection date:
Withdrawal date:

Owner

From:
17/12/2015
 
 

Name:
Galderma S.A.
Address:
Zugerstrasse 8, 6330 Cham, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
17/12/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WATKINS Gary, R.
Address:
United States (US)

2

Name:
MANETTA Vincent
Address:
United States (US)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages